Nerve Growth Factor: Physiology and What Research Reports

Nerve growth factor (NGF) is a secreted signalling protein that supports the development, survival and maintenance of specific populations of nerve cells. It was the first member of the neurotrophin family to be identified, and a review of its history and biology described it as the founding molecule of that family (PMID 34453288). Because it is a protein made of chained amino acids, NGF is often encountered in broader discussions of peptides and growth factors — although it is much larger than the short synthetic peptides that dominate those conversations.

This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, diagnosis or treatment. Nothing here describes a protocol, and no dose is presented unless a cited study reported one.

What Nerve Growth Factor Is

NGF is a neurotrophin: a small family of related proteins that act as trophic (nourishing) signals for neurons. The mature, biologically active form circulates and acts locally as a dimer, and it is produced from a larger precursor. A review of the molecule's discovery and characterisation traced how NGF became the reference point for the entire neurotrophin family and for the concept of target-derived neuronal support (PMID 34453288).

In laboratory writing it may appear as NGF, β-NGF or beta-nerve growth factor — the beta designation refers to the subunit that carries the growth-promoting activity, and serum work in primates has been published using the β-NGF label (PMID 24848615).

Where It Is Produced and What It Does

NGF is expressed by target tissues that are innervated by sensory and sympathetic neurons, as well as by immune cells, epithelial tissues and structures of the eye. It is detectable in blood, and researchers have measured serum β-NGF concentrations in cynomolgus monkeys, comparing pregnant females, non-pregnant females and males (PMID 24848615). That kind of study establishes whether a circulating level varies with physiological state before any disease comparison is attempted.

Functionally, NGF is described in the literature as a survival and maintenance factor for particular neuronal populations, and also as a signal with effects outside the nervous system — including on immune function, vascular tissue and stress responses. A review of NGF in stress and disease summarised its involvement across those systems (PMID 32811396).

Receptors: TrkA and p75NTR

NGF signals through two receptors with different consequences: the tyrosine kinase receptor TrkA and the pan-neurotrophin receptor p75NTR. Because the two can cooperate or oppose one another, the downstream picture is complex. Investigators used CRISPR/Cas9 gene editing to separate the contributions of the individual NGF receptors and reported that this approach helped disentangle the signalling complexity attributed to NGF (PMID 37036720). This matters when reading claims about "NGF effects" — the effect described often depends on which receptor a given cell type expresses.

How NGF Is Measured and Studied

Two questions dominate the methods literature: how much NGF is present, and what NGF does in a defined model.

Assay choice is not a trivial detail. Because NGF circulates at low concentrations and exists in precursor and mature forms, the methods chapter on ELISA monitoring emphasised standardised immunoassay procedure for reliable NGF detection (PMID 28501999). Numbers from different assays are therefore not automatically comparable.

What the Literature Reports

Peripheral nerve injury and regeneration

Nerve repair is the most established research context. In one animal model, researchers reported that exogenous nerve growth factor protected the hypoglossal nerve against crush injury (PMID 26889186). A separate materials-science line of work asked how to deliver NGF where it is needed: the study loaded NGF into heparin/chitosan scaffolds and reported accelerated peripheral nerve regeneration in that system (PMID 28578969). Both are preclinical findings, not clinical outcomes.

The eye

The ocular surface and retina are rich in neurotrophin biology, and a review of NGF as an ocular therapy surveyed its applications while explicitly discussing the challenges and future directions of that approach (PMID 33641595). As a regulatory fact, a recombinant human NGF ophthalmic solution has been approved for neurotrophic keratitis in the United States and Europe; most other NGF applications described in the literature remain preclinical or research-use only.

Stem cells and regenerative models

NGF has been studied as a co-factor alongside cell therapy. One study reported that nerve growth factor enhanced the therapeutic effect of mesenchymal stem cells in a model of diabetic periodontitis (PMID 34373699). In culture work, NGF was reported to promote proliferation of neural stem cells isolated from tree shrews (PMID 27212919).

Blood vessels and systemic disease

NGF is not confined to neurons. A methods chapter described the quail chorioallantoic membrane assay as a tool for studying NGF-induced angiogenesis (PMID 29222787), and a review examined nerve growth factor in the context of pulmonary hypertension (PMID 38461086). A broader review linked NGF to stress biology and to a range of disease states (PMID 32811396). Notably, these reports point in different directions depending on tissue: a growth-promoting signal can be desirable in a severed nerve and undesirable in a remodelling pulmonary artery.

Why the Term Appears in Peptide Discussions

Readers often meet "nerve growth factor" in lists of growth factors and signalling molecules. Three points are worth keeping straight. First, NGF is a full-size protein, not a short synthetic peptide. Second, the literature summarised above is overwhelmingly cell-culture, animal-model or review work rather than human outcome data. Third, because receptor context determines the response (PMID 37036720), results from one tissue do not transfer automatically to another.

Safety and Tolerability: What Studies Report

The verified literature on this page is mostly mechanistic and does not constitute a safety dataset. The ocular review framed NGF therapy as a field with unresolved challenges as well as applications (PMID 33641595), and the pulmonary hypertension review considered NGF in the context of a disease process rather than as a benign signal (PMID 38461086). A review of NGF in stress and disease similarly treated altered NGF signalling as disease-relevant (PMID 32811396). Readers should not infer tolerability in humans from preclinical reports.

Limitations of the Evidence

• Most reports cited here are in vitro, animal or review publications; species included monkeys (PMID 24848615) and tree shrews (PMID 27212919).
• Delivery method can drive the result, as in the scaffold-based nerve regeneration study (PMID 28578969).
• Measured NGF values depend on assay design, a point stressed in the ELISA methods chapter (PMID 28501999).
• Historical framing of NGF as the first neurotrophin means older claims are sometimes repeated without re-verification (PMID 34453288).

References

• Nerve Growth Factor: The First Molecule of the Neurotrophin Family (Advances in Experimental Medicine and Biology, 2021)
• ELISA for Monitoring Nerve Growth Factor (Methods in Molecular Biology, 2017)
• Serum β-nerve growth factor concentrations in pregnant female, nonpregnant female, and male cynomolgus monkeys (Neuroreport, 2014)
• Disentangling the signaling complexity of nerve growth factor receptors by CRISPR/Cas9 (FASEB Journal, 2022)
• Exogenous nerve growth factor protects the hypoglossal nerve against crush injury (Neural Regeneration Research, 2015)
• Nerve growth factor loaded heparin/chitosan scaffolds for accelerating peripheral nerve regeneration (Carbohydrate Polymers, 2017)
• Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions (Seminars in Ophthalmology, 2021)
• Nerve growth factor enhances the therapeutic effect of mesenchymal stem cells on diabetic periodontitis (Experimental and Therapeutic Medicine, 2021)
• Nerve growth factor promotes in vitro proliferation of neural stem cells from tree shrews (Neural Regeneration Research, 2016)
• Nerve Growth Factor-Induced Angiogenesis: 2. The Quail Chorioallantoic Membrane Assay (Methods in Molecular Biology, 2018)
• Nerve growth factor (NGF) in pulmonary hypertension (PH) (Revue des Maladies Respiratoires, 2024)
• Nerve Growth Factor, Stress and Diseases (Current Medicinal Chemistry, 2021)